Bryan Johnson on 5-MeO-DMT, Psychedelics, and Longevity

概览

Bryan Johnson discusses taking 5-MeO-DMT 48 hours before the recording, describing it as the most powerful psychedelic he has experienced and as an unusually intense “reset” of consciousness, ego, and self-perception.

The conversation frames psychedelics not mainly as ritual, recreation, or mental-health treatment, but as a possible longevity and brain-rejuvenation intervention. Johnson connects his 5-MeO experience to prior psilocybin experiments, default mode network changes, neuroplasticity, inflammation, glucose metabolism, and microbiome shifts.

The hosts also press on risks: psychosis, bad trips, identity disruption, changed values, founders abandoning responsibilities, and whether profound self-modification can be socially or ethically destabilizing. The discussion then broadens into mitochondrial therapy, gene and cell therapies, organoids, Yamanaka factors, GLP-1s, and the possibility that longevity technologies could reshape society.

分段落总结

[00:00] Johnson’s 5-MeO-DMT Experience Begins

[事实] Johnson says he took 5-MeO-DMT a few days earlier and describes it as the most powerful psychedelic on the planet.

[事实] He says it is somewhere between five and ten times more powerful than DMT and that, 48 hours later, he is still learning how to talk about it.

[00:54] Why He Tried It

[事实] Johnson says the main reason was a longevity experiment, consistent with his broader project of ranking interventions by evidence and effect size.

[事实] His longevity work had focused first on exercise, nutrition, sleep, sauna, hyperbaric oxygen, rapamycin, and metformin before psychedelics entered the picture.

[事实] He says psychedelics had usually been framed as ancient medicine, ritual practice, or treatment for depression and anxiety, not as rejuvenation protocols.

[事实] He says mouse evidence on psilocybin led his team to run a highly quantified experiment using three 25 mg doses.

[02:13] Trying to Describe 5-MeO

[事实] Johnson says explaining 5-MeO feels almost impossible, but describes it as encountering “raw consciousness” and “raw intelligence.”

[事实] He says the experience was not very visual, unlike DMT, and instead involved being rapidly pushed into an unfamiliar state within seconds.

[事实] He reports taking 9 mg intramuscularly and then a vaporized dose, and says the effect hit within about 10 seconds.

[03:48] Panic, Surrender, and Ego Release

[事实] Johnson says the experience presents a choice between panic and surrender.

[事实] He describes needing to release attachment, preconditions, desire, ego, and control.

[事实] He says surrender opened into extraordinary bliss and euphoria.

[推测] The key psychological pattern he emphasizes is that resisting the experience intensifies fear, while full acceptance changes its character.

[05:24] Internal Chatter and the Default Mode Network

[事实] Johnson says the experience dissolves the default mode network, which he describes as the engine that constructs self and ego.

[事实] He links the default mode network to rumination, internal monologue, self-judgment, and repetitive adult thought patterns.

[事实] He says children have a quieter default mode network, while adults develop stiffer patterns over time.

[07:13] Psilocybin, Brain Connectivity, and Neuroplasticity

[事实] Johnson compares psilocybin’s effect on the brain to rearranging airports so old traffic patterns weaken and new ones emerge.

[事实] The hosts connect this to neuroplasticity, trauma recovery, anxiety reduction, and new behavioral patterns.

[事实] Johnson says Kernel measurements showed old brain patterns quieting and new connectivity patterns appearing after psilocybin.

[09:04] Why Psychedelics Might Matter for Longevity

[事实] Johnson says mouse data suggested psilocybin had anti-inflammatory effects, and he notes inflammation is central to many longevity concerns.

[事实] He says his psilocybin experiment appeared to produce a metabolic reset, including improved blood glucose percentile and microbiome changes.

[事实] He says 5-MeO-DMT felt much stronger than psilocybin in its effect on the default mode network, which he says felt “annihilated” rather than merely dampened.

[推测] Johnson is treating brain flexibility and reduced inflammation as possible bridges between psychedelics and longevity, though he does not present completed 5-MeO data.

[10:33] Childlike Aftereffects

[事实] Johnson says he woke up laughing in a dream and felt a childlike excitement about the day after the experience.

[事实] He says he felt more renewed, playful, funny, and quick in conversation.

[事实] He describes a conflict with his partner Kate where he felt less need to defend, escalate, or weaponize the disagreement.

[推测] He interprets these changes as signs of a more flexible and less ego-protective mental state.

[12:58] Prior Psychedelic and Ketamine Experience

[事实] Johnson says he had tried hallucinogens before his current longevity project, mostly therapeutically rather than recreationally.

[事实] He says this happened after selling Braintree/Venmo, getting divorced, and leaving the Mormon Church.

[事实] He describes doing ketamine research at Kernel, measuring brain activity before, during, and after treatment.

[事实] He characterizes ketamine as minor compared with 5-MeO-DMT.

[13:52] Measurement and Brain Data

[事实] Johnson says his team collected structural MRI, functional MRI, Kernel optical-interface data, and real-time EEG for the 5-MeO experiment.

[事实] He says no objective 5-MeO results were available yet, only his subjective account.

[事实] He says rejuvenating organs such as the heart, lungs, muscle, and body fat has been easier than rejuvenating the brain.

[事实] He says prior psilocybin work showed dramatic restoration of youthful brain patterns.

[15:11] Caution Around Psychedelics

[事实] Johnson says he is more interested than ever in psychedelic compounds after seeing the data and his own experience.

[事实] He emphasizes that psychedelics are extremely powerful and should be approached carefully, with licensed professionals and appropriate conditions.

[事实] The hosts raise risks including permanent psychosis, bad trips, and triggering schizophrenic states in predisposed people.

[事实] Johnson argues many risky experiences happen with unknown doses, unknown strains, poor set and setting, and no supervision.

[17:31] Therapeutic Potential and Unknown Durability

[事实] Johnson says that subjectively, 5-MeO was more powerful than diet, exercise, sleep, sauna, and hyperbaric oxygen in resetting him as a human.

[事实] He says he does not yet know how long the effect will last or whether he will return to his previous state after 30 or 60 days.

[推测] His enthusiasm is based primarily on immediate subjective impact, while durability and objective biological outcomes remain unresolved.

[18:37] Life Disruption and Founder Risk

[事实] The hosts discuss people who took intense psychedelics and then quit companies, left families, divorced partners, or radically changed priorities.

[事实] Johnson says he has heard investors discuss adding deal terms restricting founders from taking psychedelics during a company’s life.

[事实] Johnson says his own experience made him more motivated to continue his work rather than leave it behind.

[推测] The conversation treats psychedelics as capable of producing both therapeutic insight and destabilizing life decisions.

[20:56] Identity, Values, and Personal Continuity

[事实] The hosts ask whether rewiring neurons through a drug changes whether someone remains the same person.

[事实] Johnson agrees that psychedelics can dramatically reconstruct a person and that values can change.

[事实] The discussion notes that changed values can affect duties to family, religion, partners, children, or other responsibilities.

[推测] This section frames psychedelic transformation as a philosophical and ethical issue, not just a medical or wellness topic.

[22:21] Psycho-Flexibility in an AI-Driven World

[事实] Johnson argues that as the world changes faster, especially under AI-driven innovation, humans may need tools that help them change faster.

[事实] He says psychedelics could shift from liability to asset if they help humans adapt.

[事实] A host says Johnson appears to have unusually high “psycho flexibility,” while many people may not want or tolerate overnight change.

[推测] Johnson sees psychological adaptability as a possible survival skill in fast technological change.

[23:24] Self-Modification Without Clear Limits

[事实] Johnson says he would consider neural enhancement devices, transgenic systems, plasmids, and gene-expression changes.

[事实] When asked whether there is a limit to what he would try, he says no.

[事实] He connects this openness to frontier exploration, novelty, challenge, and possibly overcompensation from a structured religious childhood.

[事实] He says he does not fully trust his own internal construction of reality and is generally suspicious of human bias.

[25:09] Responsibility to Family and Close Relationships

[事实] Johnson says he has three children and that being a father remains important to him.

[事实] He says his disposition toward fatherhood has not changed.

[事实] He says the people around him generally encourage his experimentation, while the hosts note that such support could also be seen as enabling risk.

[推测] The exchange highlights tension between personal experimentation and obligations to people affected by the outcome.

[26:17] Next Longevity Modalities

[事实] Johnson names cell therapy and gene therapy as major future areas, but says many next-generation therapies are not ready yet.

[事实] The discussion turns to mitochondrial rejuvenation and mitochondrial augmentation therapy.

[事实] The hosts describe approaches for transporting mitochondria into cells and reducing immune-system attack.

[27:47] Mitochondrial Therapy Details

[事实] Johnson says he has his first mitochondrial therapy lined up with a third-party company.

[事实] The hosts discuss using younger, maternally related mitochondria as a possible biological match.

[事实] Johnson says he expects a blood draw within the next week or two for the therapy process.

[事实] They discuss sprinting as a potentially useful way to measure mitochondrial performance effects.

[29:32] Gene Delivery, Tissue Regeneration, and Organoids

[事实] The hosts discuss plasmid-style gene delivery and a study involving tissue rejuvenation results.

[事实] Johnson says he reached out to a Chinese professor connected to that work and would like to replicate or build on it.

[事实] Johnson says his team has created induced pluripotent stem cells from his own blood and is developing Brian Johnson organoids, including heart, liver, and lung models.

[事实] He says these organoids could be used to test molecules, doses, side effects, and combinations before trying them in his body.

[32:05] Yamanaka Factors and Reprogramming Risk

[事实] Johnson says he is an investor in NewLimit and discusses progress in computational discovery around cellular reprogramming.

[事实] The hosts say a central challenge with Yamanaka factors is dosing, because overdosing even one cell could create cancer risk.

[事实] They discuss cellular switches as a possible way to control protein synthesis inside cells.

[推测] The conversation presents cellular reprogramming as extremely powerful but limited by control and safety problems.

[33:28] Longevity, Abundance, and Society

[事实] Johnson says GLP-1 drugs may be remembered as the first major shift in how people view injectable biological interventions.

[事实] He suggests future gene or reprogramming therapies could move longevity from science fiction or a rich-person pursuit toward something more broadly transformative.

[事实] The hosts argue that abundance in food, energy, housing, mobility, and lifespan tends to make people happier.

[推测] They connect better health and longevity to lower social conflict and greater optimism.

[34:33] Health, Malaise, and Psychological Outlook

[事实] Johnson says poor health, metabolic disorder, obesity, poor sleep, phone use, and mental-health issues contribute to social malaise.

[事实] He argues that when people feel healthy, they are more likely to believe they can do hard things.

[事实] He links individual health to the psychological disposition of communities and countries.

[35:08] Why Psychedelics Still Matter

[事实] The hosts ask why psychedelics matter if other biological therapies may produce profound effects.

[事实] Johnson says the brain is complicated and hard to rejuvenate, and some therapies may not meaningfully affect it.

[事实] He says psychedelics may be uniquely powerful for restoring a youthful disposition toward reality, ambition, and possibility.

[事实] He says 5-MeO felt like 30 or 40 years of psychological rejuvenation and returned him to a childlike state.

[37:16] Closing Contrast

[事实] The episode ends with a light contrast between the host joking about alcohol, carbohydrates, and staying up late, while Johnson says he will go to bed on time and follow his wind-down routine.

播客点评/总结

[推测] This episode is valuable because it treats psychedelics as both a subjective human experience and a possible measurable biological intervention. The strongest part is the tension between Johnson’s intense personal testimony and the hosts’ repeated pressure on safety, identity, and social consequences.

[推测] The discussion is less conclusive on evidence. Johnson repeatedly emphasizes measurement, but the 5-MeO data had not yet been analyzed, so the most dramatic claims in this episode remain experiential rather than demonstrated.

[推测] The episode is best suited for listeners interested in longevity, neuroscience, psychedelics, self-experimentation, and frontier biotech. It is less suitable as practical medical guidance, because the conversation itself stresses that these compounds carry serious risks and require careful supervision.